These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8965197)

  • 21. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
    Hernandez CM; Gearhart DA; Parikh V; Hohnadel EJ; Davis LW; Middlemore ML; Warsi SP; Waller JL; Terry AV
    J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
    Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
    Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p-[18F]fluorobenzyltrozamicol ([18F]FBT): molecular decomposition- reconstitution approach to vesamicol receptor radioligands for positron emission tomography.
    Efange SM; Mach RH; Khare A; Michelson RH; Nowak PA; Evora PH
    Appl Radiat Isot; 1994 Apr; 45(4):465-72. PubMed ID: 8186771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.
    Altar CA; Marien MR
    Synapse; 1988; 2(5):486-93. PubMed ID: 2973145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution and radiation dosimetry of radioiodinated-SCH 23982, a potential dopamine D-1 receptor imaging agent.
    Thonoor CM; Couch MW; Greer DM; Thomas KD; Williams CM
    J Nucl Med; 1988 Oct; 29(10):1668-74. PubMed ID: 3262726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides.
    Kessler RM; Ansari MS; de Paulis T; Schmidt DE; Clanton JA; Smith HE; Manning RG; Gillespie D; Ebert MH
    J Nucl Med; 1991 Aug; 32(8):1593-600. PubMed ID: 1831229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of radioiodinated (-)-o-iodovesamicol as a radiotracer for mapping the vesicular acetylcholine transporter.
    Shiba K; Mori H; Tonami N
    Ann Nucl Med; 2003 Sep; 17(6):451-6. PubMed ID: 14575378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA; Mansour A; Watson SJ
    Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
    Joyce JN
    Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of physiologic factors on the expression of striatal dopamine D2 receptors].
    Cao G; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):5-6. PubMed ID: 12501598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.
    Mulholland GK; Wieland DM; Kilbourn MR; Frey KA; Sherman PS; Carey JE; Kuhl DE
    Synapse; 1998 Nov; 30(3):263-74. PubMed ID: 9776130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
    Leysen JE; Janssen PM; Gommeren W; Wynants J; Pauwels PJ; Janssen PA
    Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioiodinated 2-hydroxy-3-(4-iodophenyl)-1-(4-phenylpiperidinyl)propane: potential radiotracer for mapping central cholinergic innervation in vitro.
    Efange SM; Dutta AK; Michelson RH; Kung HF; Thomas JR; Billings J; Boudreau RJ
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):337-48. PubMed ID: 1629023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.